158 related articles for article (PubMed ID: 2226609)
1. Immunotherapy for advanced renal cell cancer: the role of radical nephrectomy.
Belldegrun A; Koo AS; Bochner B; Figlin R; deKernion JB
Eur Urol; 1990; 18 Suppl 2():42-5. PubMed ID: 2226609
[No Abstract] [Full Text] [Related]
2. Management of advanced renal cancer.
Atkins MB
Kidney Int; 2005 May; 67(5):2069-82. PubMed ID: 15840065
[No Abstract] [Full Text] [Related]
3. The role of adjuvant immunotherapy after radical nephrectomy and prognostic factors in pT3N0M0 renal cell carcinoma.
Jeon SH; Chang SG; Kim JI
Anticancer Res; 1999; 19(6C):5593-7. PubMed ID: 10697624
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant therapy with vinblastine and interferon in metastatic renal carcinoma].
Cocimano V; Marino G; Brigato R; Cevoli R; Griffa D
Minerva Urol Nefrol; 1989; 41(3):187-9. PubMed ID: 2617374
[TBL] [Abstract][Full Text] [Related]
5. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
[TBL] [Abstract][Full Text] [Related]
6. Does vinblastine add to the potency of alpha interferon in the treatment of renal cell carcinoma?
Merimsky O; Shnider BI; Chaitchik S
Mol Biother; 1991 Mar; 3(1):34-7. PubMed ID: 2069758
[TBL] [Abstract][Full Text] [Related]
7. Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patients.
Bergerat JP; Ford J; Herbrecht R; Dufour P; Oberling F; Jacqmin D; Bollack C; Prevot G; Salze P; Jurascheck F
Prog Clin Biol Res; 1990; 348():137-50. PubMed ID: 2385604
[No Abstract] [Full Text] [Related]
8. Metastasectomy plus immunotherapy compared with immunotherapy alone in metastatic renal cell carcinoma.
Ku JH; Kwak C
Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):164-5. PubMed ID: 17355116
[No Abstract] [Full Text] [Related]
9. Is there a role for adjuvant immunochemotherapy after radical nephrectomy in pT2-3N0M0 renal cell carcinoma?
Migliari R; Muscas G; Solinas A; Melis M; Ionta MT; Massidda B; Usai E
J Chemother; 1995 Jun; 7(3):240-5. PubMed ID: 7562021
[TBL] [Abstract][Full Text] [Related]
10. [Metastasizing kidney cancer. Experience with interferon alfa-2a and vinblastine].
González Enguita C; Roncalés Badal A; Gil Sanz MJ; Martínez Bengoechea J; Tello Royloa C; Rioja Sanz LA
Actas Urol Esp; 1990; 14(5):335-8. PubMed ID: 2288249
[TBL] [Abstract][Full Text] [Related]
11. Human lymphoblastoid interferon therapy for advanced renal cell carcinoma.
Marumo K; Murai M; Hayakawa M; Tazaki H
Urology; 1984 Dec; 24(6):567-71. PubMed ID: 6506397
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinoma.
Schornagel JH; Verweij J; ten Bokkel Huinink WW; Klijn JG; de Mulder PH; Debruyne FM; van Deijk WA; Roozendaal K; Kok TC; Veenhof KH
J Urol; 1989 Aug; 142(2 Pt 1):253-6. PubMed ID: 2746739
[TBL] [Abstract][Full Text] [Related]
13. Interferon therapy for renal cell carcinoma.
Muss HB
Semin Oncol; 1987 Jun; 14(2 Suppl 2):36-42. PubMed ID: 3589703
[TBL] [Abstract][Full Text] [Related]
14. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.
Mickisch GH; Garin A; van Poppel H; de Prijck L; Sylvester R;
Lancet; 2001 Sep; 358(9286):966-70. PubMed ID: 11583750
[TBL] [Abstract][Full Text] [Related]
15. [Alpha 2-interferon in kidney cancer. Experiences with 6 patients].
Weidmann B; Hoffmann W; Seeber S
Onkologie; 1990 Jun; 13(3):217-20. PubMed ID: 2204010
[TBL] [Abstract][Full Text] [Related]
16. Does radical nephrectomy with immunochemotherapy have any superiority over embolization alone in metastatic renal cell carcinoma? A preliminary report.
Demirci D; Tatlişen A; Ekmekçioğlu O; Ozcan N; Kaya R
Urol Int; 2004; 73(1):54-8. PubMed ID: 15263794
[TBL] [Abstract][Full Text] [Related]
17. Role of interferons in the therapy of metastatic renal cell carcinoma.
Quesada JR
Urology; 1989 Oct; 34(4 Suppl):80-3; discussion 87-96. PubMed ID: 2678687
[TBL] [Abstract][Full Text] [Related]
18. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
19. Management of disseminated kidney cancer.
Taneja SS; Pierce W; Figlin R; Belldegrun A
Urol Clin North Am; 1994 Nov; 21(4):625-37. PubMed ID: 7974894
[TBL] [Abstract][Full Text] [Related]
20. The treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
Kotake T; Kinouchi T
Prog Clin Biol Res; 1989; 303():661-9. PubMed ID: 2780667
[No Abstract] [Full Text] [Related]
[Next] [New Search]
